{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:34:19Z","timestamp":1781883259226,"version":"3.54.5"},"reference-count":30,"publisher":"Japan Atherosclerosis Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,2,1]]},"DOI":"10.5551\/jat.65812","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T22:07:21Z","timestamp":1756505241000},"page":"181-194","source":"Crossref","is-referenced-by-count":2,"title":["Joint Impact of Smoking and Metabolic Syndrome on Cardiovascular Disease: A Cohort Study"],"prefix":"10.5551","volume":"33","author":[{"given":"Huan","family":"Hu","sequence":"first","affiliation":[{"name":"Research Center for Prevention from Radiation Hazards of Workers, National Institute of Occupational Safety and Health"},{"name":"Department of Epidemiology and Prevention, Center for Clinical Sciences, Japan Institute for Health Security"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Hitachi Health Care Center, Hitachi, Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Honda","sequence":"additional","affiliation":[{"name":"Hitachi Health Care Center, Hitachi, Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Hitachi Health Care Center, Hitachi, Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Mitsui Chemicals, Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ide","sequence":"additional","affiliation":[{"name":"Mitsui Chemicals, Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seitaro","family":"Dohi","sequence":"additional","affiliation":[{"name":"Mitsui Chemicals, Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"NIPPON STEEL CORPORATION, EAST NIPPON WORKS Kimitsu Area"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"YAMAHA CORPORATION"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Gommori","sequence":"additional","affiliation":[{"name":"East Japan Works (Keihin), JFE Steel Corporation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kochi","sequence":"additional","affiliation":[{"name":"Furukawa Electric Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ogasawara","sequence":"additional","affiliation":[{"name":"Mitsubishi Fuso Truck and Bus Corporation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Prevention, Center for Clinical Sciences, Japan Institute for Health Security"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Kabe","sequence":"additional","affiliation":[{"name":"KUBOTA Corporation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Mizoue","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Prevention, Center for Clinical Sciences, Japan Institute for Health Security"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Mensah GA, Fuster V, Murray CJL, Roth GA; Global Burden of Cardiovascular Diseases and Risks Collaborators. Global Burden of Cardiovascular Diseases and Risks, 1990-2022. J Am Coll Cardiol, 2023; 82: 2350-2473","DOI":"10.1016\/j.jacc.2023.11.007"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Iso H. Cardiovascular disease, a major global burden: Epidemiology of stroke and ischemic heart disease in Japan. Glob Health Med, 2021; 3: 358-364","DOI":"10.35772\/ghm.2020.01113"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ohira T, Eguchi E, Hayashi F, Kinuta M, Imano H. Epidemiology of cardiovascular disease in Japan: An overview study. J Cardiol, 2024; 83: 191-200","DOI":"10.1016\/j.jjcc.2023.08.006"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Li J, Imano H, Kitamura A, Kiyama M, Yamagishi K, Tanaka M, Ohira T, Sankai T, Umesawa M, Muraki I, Hayama-Terada M, Cui R, Shimizu Y, Okada T, Sato S, Tanigawa T, Iso H. Trends in the incidence of stroke and its subtypes from 1963 to 2018 in Japanese urban and rural communities: The Circulatory Risk in Communities Study (CIRCS). Int J Stroke, 2023; 18: 657-662","DOI":"10.1177\/17474930221135531"},{"key":"5","unstructured":"5) Statistics of Japan. Mortality Rates and Number of Deaths by Cause of Death (Time-Series Classification), Sex, 5-Year Age Group, and Year (per 100,000 Population). https: \/\/www.estat.go.jp\/en; Accessed 12.07.2024"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kondo T, Nakano Y, Adachi S, Murohara T. Effects of Tobacco Smoking on Cardiovascular Disease. Circ J, 2019; 83: 1980-1985","DOI":"10.1253\/circj.CJ-19-0323"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol, 2010; 56: 1113-1132","DOI":"10.1016\/j.jacc.2010.05.034"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kopp W. Pathogenesis of (smoking-related) non-communicable diseases-Evidence for a common underlying pathophysiological pattern. Front Physiol, 2022; 13: 1037750","DOI":"10.3389\/fphys.2022.1037750"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Behl TA, Stamford BA, Moffatt RJ. The Effects of Smoking on the Diagnostic Characteristics of Metabolic Syndrome: A Review. Am J Lifestyle Med, 2022; 17: 397-412","DOI":"10.1177\/15598276221111046"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kim CY, Lee CM, Lee S, Yoo JE, Lee H, Park HE, Han K, Choi SY. The Association of Smoking Status and Clustering of Obesity and Depression on the Risk of Early-Onset Cardiovascular Disease in Young Adults: A Nationwide Cohort Study. Korean Circ J, 2023; 53: 17-30","DOI":"10.4070\/kcj.2022.0179"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Yang Y, Peng N, Chen G, Wan Q, Yan L, Wang G, Qin Y, Luo Z, Tang X, Huo Y, Hu R, Ye Z, Qin G, Gao Z, Su Q, Mu Y, Zhao J, Chen L, Zeng T, Yu X, Li Q, Shen F, Chen L, Zhang Y, Wang Y, Deng H, Liu C, Wu S, Yang T, Li M, Xu Y, Xu M, Zhao Z, Wang T, Lu J, Bi Y, Wang W, Ning G, Zhang Q, Shi L. Interaction between smoking and diabetes in relation to subsequent risk of cardiovascular events. Cardiovasc Diabetol, 2022; 21: 14","DOI":"10.1186\/s12933-022-01447-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Tan J, Zhang X, Wang W, Yin P, Guo X, Zhou M. Smoking, Blood Pressure, and Cardiovascular Disease Mortality in a Large Cohort of Chinese Men with 15 Years Follow-up. Int J Environ Res Public Health, 2018; 15: 1026","DOI":"10.3390\/ijerph15051026"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Takashima N, Miura K, Hozawa A, Kadota A, Okamura T, Nakamura Y, Hayakawa T, Okuda N, Fujiyoshi A, Nagasawa SY, Kadowaki T, Murakami Y, Kita Y, Okayama A, Ueshima H; NIPPON DATA 90 Research Group. Population attributable fraction of smoking and metabolic syndrome on cardiovascular disease mortality in Japan: a 15-year follow up of NIPPON DATA90. BMC Public Health, 2010; 10: 306","DOI":"10.1186\/1471-2458-10-306"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Higashiyama A, Okamura T, Ono Y, Watanabe M, Kokubo Y, Okayama A. Risk of smoking and metabolic syndrome for incidence of cardiovascular disease--comparison of relative contribution in urban Japanese population: the Suita study. Circ J, 2009; 73: 2258-2263","DOI":"10.1253\/circj.CJ-09-0264"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Zhang L, Guo Z, Wu M, Hu X, Xu Y, Zhou Z. Interaction of smoking and metabolic syndrome on cardiovascular risk in a Chinese cohort. Int J Cardiol, 2013; 167: 250-253","DOI":"10.1016\/j.ijcard.2011.12.079"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Fujita T, Babazono A, Harano Y, Jiang P. Influence of Occupational Background on Smoking Prevalence as a Health Inequality Among Employees of Medium- and Small-Sized Companies in Japan. Popul Health Manag, 2020; 23: 183-193","DOI":"10.1089\/pop.2019.0021"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Van Hoang D, Inoue Y, Fukunaga A, Nakagawa T, Honda T, Yamamoto S, et al. Metabolic syndrome and the risk of severe cancer events: a longitudinal study in Japanese workers. BMC Cancer, 2023; 23: 555","DOI":"10.1186\/s12885-023-11026-7"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hu H, Fukunaga A, Yokoya T, Nakagawa T, Honda T, Yamamoto S, Okazaki H, Miyamoto T, Sasaki N, Ogasawara T, Gonmori N, Yamamoto K, Hori A, Tomita K, Nagahama S, Konishi M, Katayama N, Morioka H, Kabe I, Mizoue T, Dohi S. Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease: The Japan Epidemiology Collaboration on Occupational Health Study. J Atheroscler Thromb, 2022; 29: 1295-1306","DOI":"10.5551\/jat.63118"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, Ito M, Ito S, Iwashima Y, Kai H, Kamide K, Kanno Y, Kashihara N, Kawano Y, Kikuchi T, Kitamura K, Kitazono T, Kohara K, Kudo M, Kumagai H, Matsumura K, Matsuura H, Miura K, Mukoyama M, Nakamura S, Ohkubo T, Ohya Y, Okura T, Rakugi H, Saitoh S, Shibata H, Shimosawa T, Suzuki H, Takahashi S, Tamura K, Tomiyama H, Tsuchihashi T, Ueda S, Uehara Y, Urata H, Hirawa N. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res, 2019; 42: 1235-1481","DOI":"10.1038\/s41440-019-0284-9"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) American diabetes association. standards of medical care in Diabetes\u20132022. Diabetes Care, 2022; 45: S17-38","DOI":"10.2337\/dc22-S002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, Ohmura H, Shoji T, Yokote K, Yoshida H, Yoshida M, Deguchi J, Dobashi K, Fujiyoshi A, Hamaguchi H, Hara M, Harada-Shiba M, Hirata T, Iida M, Ikeda Y, Ishibashi S, Kanda H, Kihara S, Kitagawa K, Kodama S, Koseki M, Maezawa Y, Masuda D, Miida T, Miyamoto Y, Nishimura R, Node K, Noguchi M, Ohishi M, Saito I, Sawada S, Sone H, Takemoto M, Wakatsuki A, Yanai H. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022. J Atheroscler Thromb, 2024; 31: 641-853","DOI":"10.5551\/jat.GL2022"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 2009; 120: 1640-1645","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Salter A. Assessment of Biological Interactions Between Multiple Sclerosis Status and Depression for Mortality. Neurology, 2021; 97: 617-618","DOI":"10.1212\/WNL.0000000000012615"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Andersson T, Alfredsson L, K\u00e4llberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol, 2005; 20: 575-579","DOI":"10.1007\/s10654-005-7835-x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Cardiovascular consequences of metabolic syndrome. Transl Res, 2017; 183: 57-70","DOI":"10.1016\/j.trsl.2017.01.001"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Sun K, Liu J, Ning G. Active smoking and risk of metabolic syndrome: a meta-analysis of prospective studies. PLoS One, 2012; 7: e47791","DOI":"10.1371\/journal.pone.0047791"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Hackshaw A, Morris JK, Boniface S, Tang JL, Milenkovi\u0107 D. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ, 2018; 360: j5855","DOI":"10.1136\/bmj.j5855"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Hu H, Nakagawa T, Honda T, Yamamoto S, Nanri A, Konishi M, Okazaki H, Kuwahara K, Hori A, Nishiura C, Kashino I, Imai T, Nishihara A, Akter S, Miyamoto T, Sasaki N, Ogasawara T, Uehara A, Yamamoto M, Murakami T, Shimizu M, Eguchi M, Kochi T, Nagahama S, Tomita K, Kabe I, Mizoue T, Sone T, Dohi S; Japan Epidemiology Collaboration on Occupational Health Study Group. Metabolic Syndrome Over 4 Years Before the Onset of Cardiovascular Disease-Nested Case-Control Study. Circ J, 2018; 82: 430-436","DOI":"10.1253\/circj.CJ-17-0513"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Wang Z, Chen J, Zhu L, Jiao S, Chen Y, Sun Y. Metabolic disorders and risk of cardiovascular diseases: a two-sample mendelian randomization study. BMC Cardiovasc Disord, 2023; 23: 529","DOI":"10.1186\/s12872-023-03567-3"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Guembe MJ, Fernandez-Lazaro CI, Sayon-Orea C, Toledo E, Moreno-Iribas C; RIVANA Study Investigators. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort. Cardiovasc Diabetol, 2020; 19: 195","DOI":"10.1186\/s12933-020-01166-6"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/2\/33_65812\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:59:51Z","timestamp":1770436791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/2\/33_65812\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65812","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"article-number":"65812"}}